Clinical trial

The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia

NCT00523445

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-09-01

PhasePHASE3

Study timeline

Study start (unknown)2007-09-01Date precision: month

Registry last updated2009-08-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Varenicline(Chantix)DRUG

PlaceboDRUG

Sponsors & collaborators

Inje Universitylead sponsor

Stanley Medical Research Institutecollaborator

Mapped research locations

BusanSouth Korea4

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00523445 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.